menu
    • menu

    Company profile for Kamari Pharma

    NEW Drugs in Dev: 4
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kamari was established at the end of 2018 by the Israeli based biotechnology funds Pontifax and Arkin Bioholdings. Up to the current investment, $16 million were invested in Kamari. The company develops topical and oral drugs based on proprietary small molecules that inhibit an ion channel designated TRPV3. These drugs are intended for the treatment of various dermatological diseases, such as keratoderma, Lichen Simplex Chroni...
    Kamari was established at the end of 2018 by the Israeli based biotechnology funds Pontifax and Arkin Bioholdings. Up to the current investment, $16 million were invested in Kamari. The company develops topical and oral drugs based on proprietary small molecules that inhibit an ion channel designated TRPV3. These drugs are intended for the treatment of various dermatological diseases, such as keratoderma, Lichen Simplex Chronicus and other severe genetic skin disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kamari PharmaIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    Pinchas Sapir 3, Science park, Ness Ziona
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kamaripharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kamari Pharma closes $23M financing for rare skin disease drug
    Kamari Pharma closes $23M financing for rare skin disease drug

    03 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/03/3092474/0/en/Kamari-Pharma-Announces-Closing-of-23-Million-Financing-to-Advance-its-First-In-Class-Oral-TRPV3-Inhibitor-for-Rare-Genetic-Skin-Diseases.html

    GLOBENEWSWIRE
    03 Jun 2025
    Share Share
    Kamari Pharma to Present at 82nd Annual Meet IPCC & DHHD
    Kamari Pharma to Present at 82nd Annual Meet IPCC & DHHD

    08 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/08/3077121/0/en/Kamari-Pharma-Announces-Presentations-at-the-82nd-Annual-Meeting-of-the-Society-for-Investigative-Dermatology-and-the-International-Pachyonychia-Congenita-Consortium-Symposium.html

    GLOBENEWSWIRE
    08 May 2025
    Share Share
    Kamari Presents New Data At SID Annual Meeting
    Kamari Presents New Data At SID Annual Meeting

    17 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/17/2884446/0/en/Kamari-Pharma-Announces-New-Data-Presented-at-the-81st-Annual-Meeting-of-the-Society-for-Investigative-Dermatology.html

    GLOBENEWSWIRE
    17 May 2024
    Share Share
    Kamari Pharma Abstracts Accepted for Dermatology Society Meeting
    Kamari Pharma Abstracts Accepted for Dermatology Society Meeting

    16 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/16/2864091/0/en/Kamari-Pharma-Announces-Abstracts-Accepted-for-Presentation-at-the-81st-Annual-Meeting-of-the-Society-for-Investigative-Dermatology.html

    GLOBENEWSWIRE
    16 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search